IndraLab
Statements
sparser
"Palmitic acid is a crucial precursor for the synthesis of sphingomyelin. [ xref ] We found that enzalutamide‐resistant prostate cancer is closely associated with phospholipid metabolism (specifically sphingomyelin rather than other phospholipid types), and that palmitic acid, a key substrate for sphingomyelin synthesis, is elevated in this context. [ xref ] High levels of palmitate activate prostate cancer cells and promote disease progression. [ xref ] As a substrate for palmitoylation, palmitic acid functions through palmitoyltransferases, which transfer palmitoyl groups to cysteine residues on target proteins. [ xref ] Some studies report that ZDHHC7 and ZDHHC21 enhance AR S‐palmitoylation, promoting prostate cancer progression and abiraterone resistance. [ xref ] Additionally, Wnt‐1 palmitoylation and subsequent pathway activation stabilize β‐catenin, representing a potential oncogenic mechanism in prostate cancer. [ xref ] Among all palmitoyl transferases, we found that only ZDHHC2 is significantly increased in prostate cancer during enzalutamide resistance."